The ratio of tumor-infiltrating CD4+ and CD8+ T cells was decreased after treatment with a low dose of cisplatin (1 mg/kg), although the ratio of total lymphocytes and T cells was slightly increased (Fig. 8A–D). This evidence concerns the gene CD8A and neoplasm.